Smoking cessation and outcome after ischemic stroke or TIA

Neurology

Volumn 89, Issue 16, 2017, Pages 1723-1729

  Epstein, Katherine A ^a   Viscoli, Catherine M ^a   Spence, J David ^b   Young, Lawrence H ^a   Inzucchi, Silvio E ^a   Gorman, Mark ^b   Gerstenhaber, Brett ^a   Guarino, Peter D ^c   Dixit, Anand ^d   Furie, Karen L ^e,f   Kernan, Walter N ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c MAINE MEDICAL CENTER   (United States)

^d USA   (United States)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PIOGLITAZONE; PLACEBO; TRIACYLGLYCEROL;

ADULT; ARTICLE; BRAIN ISCHEMIA; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEATH; DIASTOLIC BLOOD PRESSURE; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TOBACCO USE; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; TREATMENT OUTCOME; AGED; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; MYOCARDIAL INFARCTION; PROCEDURES; PROPORTIONAL HAZARDS MODEL; SMOKING; STROKE; THERAPY;

AGED; COHORT STUDIES; FEMALE; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; SMOKING; SMOKING CESSATION; STROKE;

EID: 85031431074     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000004524     Document Type: Article

References (38)

1. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics-2016 update: A report from the American Heart Association. Circulation 2016;133:e38-e360.
2. Bonita R, Scragg R, Stewart A, Jackson R, Beaglehole R. Cigarette smoking and risk of premature stroke in men and women. Br Med J (Clin Res Ed) 1986;293:6-8.
3. O'Donnell MJ, Chin SL, Rangarajan S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): A case-control study. Lancet 2016;388: 761-775.
4. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM. Current cigarette smoking among adults-United States, 2005-2015. MMWR Morb Mortal Wkly Rep 2016;65:1205-1211.
5. Meschia JF, Bushnell C, Boden-Albala B, et al. Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:3754-3832.
6. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:2160-2236.
7. Kernan WN, Viscoli CM, Furie KL, et al. Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med 2016;374:1321-1331.
8. Viscoli CM, Brass LM, Carolei A, et al. Pioglitazone for secondary prevention after ischemic stroke and transient ischemic attack: Rationale and design of the Insulin Resistance Intervention after Stroke Trial. Am Heart J 2014; 168:823-829.e826.
9. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
10. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: A systematic review. JAMA 2003;290:86-97.
11. Rallidis LS, Sakadakis EA, Tympas K, et al. The impact of smoking on long-term outcome of patients with premature (,/535years) ST-segment elevation acute myocardial infarction. Am Heart J 2015;169:356-362.
12. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 2002;137:494-500.
13. Kaplan EL, Meier P. Nonparametric-estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-220.
15. Heron M. Deaths: Leading causes for 2013. Natl Vital Stat Rep 2016;65:1-95.
16. Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
17. Kernan WN, Viscoli CM, Brass LM, et al. The Stroke Prognosis Instrument II (SPI-II): A clinical prediction instrument for patients with transient ischemia and nondisabling ischemic stroke. Stroke 2000;31:456-462.
18. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978;299:53-59.
19. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-1041.
20. European Atrial Fibrillation Trial Study Group. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342: 1255-1262.
21. Alvarez LR, Balibrea JM, Surinach JM, et al. Smoking cessation and outcome in stable outpatients with coronary, cerebrovascular, or peripheral artery disease. Eur J Prev Cardiol 2013;20:486-495.
22. Kumagai N, Okuhara Y, Iiyama T, et al. Effects of smoking on outcomes after acute atherothrombotic stroke in Japanese men. J Neurol Sci 2013;335:164-168.
23. Ovbiagele B, Weir CJ, Saver JL, Muir KW, Lees KR; IMAGES Investigators. Effect of smoking status on outcome after acute ischemic stroke. Cerebrovasc Dis 2006; 21:260-265.
24. Kim J, Gall SL, Dewey HM, Macdonell RA, Sturm JW, Thrift AG. Baseline smoking status and the long-term risk of death or nonfatal vascular event in people with stroke: A 10-year survival analysis. Stroke 2012; 43:3173-3178.
25. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol 2004;43:1731-1737.
26. Rothwell M, Rampling MW, Cholerton S, Sever PS. Haemorheological changes in the very short term after abstention from tobacco by cigarette smokers. Br J Haematol 1991;79:500-503.
27. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232-236.
28. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: The Framingham Study. JAMA 1988;259:1025-1029.
29. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
30. Parsons A, Daley A, Begh R, Aveyard P. Influence of smoking cessation after diagnosis of early stage lung cancer on prognosis: Systematic review of observational studies with meta-analysis. BMJ 2010;340:b5569.
31. Dobson Amato KA, Hyland A, Reed R, et al. Tobacco cessation may improve lung cancer patient survival. J Thorac Oncol 2015;10:1014-1019.
32. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 1993;328: 159-163.
33. Johnston-Early A, Cohen MH, Minna JD, et al. Smoking abstinence and small cell lung cancer survival: An association. JAMA 1980;244:2175-2179.
34. Chernyavsky AI, Shchepotin IB, Galitovkiy V, Grando SA. Mechanisms of tumor-promoting activities of nicotine in lung cancer: Synergistic effects of cell membrane and mitochondrial nicotinic acetylcholine receptors. BMC Cancer 2015;15:152.
35. Sobus SL, Warren GW. The biologic effects of cigarette smoke on cancer cells. Cancer 2014;120:3617-3626.
36. Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA 2013;309:1014-1021.
37. Jimenez-Ruiz CA, Andreas S, Lewis KE, et al. Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit. Eur Respir J 2015;46:61-79.
38. Barrett-Connor E. Postmenopausal estrogen and prevention bias. Ann Intern Med 1991;115:455-456.